The Independent Association of TSH and Free Triiodothyronine Levels With Lymphocyte Counts Among COVID-19 Patients.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Lausanne : Frontiers Research Foundation]
    • Subject Terms:
    • Abstract:
      Background: Both lymphopenia and thyroid dysfunction are commonly observed among COVID-19 patients. Whether thyroid function independently correlates with lymphocyte counts (LYM) remains to be elucidated.
      Methods: We included consecutive adults without known thyroid disorder admitted to Queen Mary Hospital for COVID-19 from July 2020 to April 2021 who had thyroid-stimulating hormone (TSH), free thyroxine (fT4), free triiodothyronine (fT3) and LYM measured on admission.
      Results: A total of 541 patients were included. Median LYM was 1.22 x 10 9 /L, with 36.0% of the cohort lymphopenic. 83 patients (15.4%) had abnormal thyroid function tests (TFTs), mostly non-thyroidal illness syndrome (NTIS). Patients with lymphopenia had lower TSH, fT4 and fT3 levels than those without. Multivariable stepwise linear regression analysis revealed that both TSH (standardized beta 0.160, p<0.001) and fT3 (standardized beta 0.094, p=0.023), but not fT4, remained independently correlated with LYM, in addition to age, SARS-CoV-2 viral load, C-reactive protein levels, coagulation profile, sodium levels and more severe clinical presentations. Among the 40 patients who had reassessment of TFTs and LYM after discharge, at a median of 9 days from admission, there were significant increases in TSH (p=0.031), fT3 (p<0.001) and LYM (p<0.001). Furthermore, patients who had both lymphopenia and NTIS were more likely to deteriorate compared to those who only had either one alone, and those without lymphopenia or NTIS (p for trend <0.001).
      Conclusion: TSH and fT3 levels showed independent positive correlations with LYM among COVID-19 patients, supporting the interaction between the hypothalamic-pituitary-thyroid axis and immune system in COVID-19.
      Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
      (Copyright © 2022 Lui, Lee, Chow, Lee, Tam, Pang, Ho, Cheung, Fong, Law, To, Lam, Tan, Woo, Hung and Lam.)
    • References:
      Blood. 2007 May 1;109(9):3812-9. (PMID: 17255361)
      Clin Infect Dis. 2020 Jul 28;71(15):793-798. (PMID: 32221523)
      J Clin Endocrinol Metab. 2021 Jun 16;106(7):1994-2009. (PMID: 33713408)
      BMC Endocr Disord. 2021 May 27;21(1):111. (PMID: 34044831)
      Pediatrics. 2018 Jan;141(1):. (PMID: 29242269)
      J Endocr Soc. 2021 Apr 27;5(8):bvab076. (PMID: 34189381)
      Clin Infect Dis. 2020 Nov 19;71(16):2252-2254. (PMID: 32435816)
      J Med Virol. 2020 Nov;92(11):2725-2734. (PMID: 32501535)
      Endocr Rev. 2011 Oct;32(5):670-93. (PMID: 21791567)
      Thyroid. 2020 Dec;30(12):1695-1709. (PMID: 32349628)
      J Allergy Clin Immunol. 2020 Jul;146(1):128-136.e4. (PMID: 32425269)
      Nature. 2020 Dec;588(7837):315-320. (PMID: 32846427)
      Infect Dis Poverty. 2020 Apr 28;9(1):45. (PMID: 32345362)
      Lancet. 2020 May 30;395(10238):1695-1704. (PMID: 32401715)
      Kidney Int Suppl (2011). 2013 Jan;3(1):19-62. (PMID: 25018975)
      Clin Endocrinol (Oxf). 2021 Sep;95(3):469-477. (PMID: 33813743)
      Int J Immunopharmacol. 1992 Jul;14(5):865-70. (PMID: 1512078)
      CMAJ. 2020 Jan 13;192(2):E25-E33. (PMID: 31932337)
      Trials. 2020 Jun 26;21(1):573. (PMID: 32586399)
      J Clin Endocrinol Metab. 2021 Jan 23;106(2):e926-e935. (PMID: 33141191)
      J Endocrinol. 2006 Apr;189(1):45-55. (PMID: 16614380)
      Nat Immunol. 2004 Feb;5(2):133-9. (PMID: 14749784)
      Life Sci. 2020 Sep 15;257:118097. (PMID: 32679148)
      Scand J Immunol. 2021 Feb;93(2):e12967. (PMID: 32875598)
      J Endocrinol Invest. 2021 Dec;44(12):2735-2739. (PMID: 34101132)
      Horm Res. 1995;43(1-3):29-38. (PMID: 7721259)
      Int J Lab Hematol. 2020 Jun;42 Suppl 1:11-18. (PMID: 32311826)
      Leuk Lymphoma. 2020 Dec;61(12):2790-2798. (PMID: 32643489)
      J Endocrinol Invest. 2020 Aug;43(8):1137-1139. (PMID: 32451971)
      Endocr Pract. 2021 Sep;27(9):894-902. (PMID: 34237471)
      Front Immunol. 2021 Aug 09;12:720090. (PMID: 34434199)
      Front Endocrinol (Lausanne). 2020 Nov 20;11:543845. (PMID: 33329378)
      Blood Rev. 2021 Mar;46:100743. (PMID: 32829962)
      Immunol Lett. 2017 Apr;184:76-83. (PMID: 28216261)
      Ann Hematol. 2021 Feb;100(2):309-320. (PMID: 33415422)
      Int J Oral Sci. 2020 Feb 24;12(1):8. (PMID: 32094336)
      Front Endocrinol (Lausanne). 2021 Feb 19;11:623792. (PMID: 33679608)
      J Endocrinol. 2009 Jul;202(1):55-63. (PMID: 19398496)
      J Clin Endocrinol Metab. 2020 Jul 1;105(7):. (PMID: 32436948)
      Endocrinol Metab (Seoul). 2021 Jun;36(3):582-589. (PMID: 34107601)
    • Contributed Indexing:
      Keywords: COVID-19; SARS-CoV-2; euthyroid sick syndromes; lymphocytes; lymphopenia; thyroid function tests
    • Accession Number:
      0 (Thyroid Hormones)
      06LU7C9H1V (Triiodothyronine)
      9002-71-5 (Thyrotropin)
    • Publication Date:
      Date Created: 20220131 Date Completed: 20220204 Latest Revision: 20231105
    • Publication Date:
      20231105
    • Accession Number:
      PMC8792436
    • Accession Number:
      10.3389/fendo.2021.774346
    • Accession Number:
      35095756